LT2846805T - Priklausomybių ir impulsų kontrolės sutrikimų gydymas, panaudojant pde7 inhibitorius - Google Patents

Priklausomybių ir impulsų kontrolės sutrikimų gydymas, panaudojant pde7 inhibitorius

Info

Publication number
LT2846805T
LT2846805T LTEP13793319.8T LT13793319T LT2846805T LT 2846805 T LT2846805 T LT 2846805T LT 13793319 T LT13793319 T LT 13793319T LT 2846805 T LT2846805 T LT 2846805T
Authority
LT
Lithuania
Prior art keywords
addiction
impulse
treatment
control disorders
pde7 inhibitors
Prior art date
Application number
LTEP13793319.8T
Other languages
English (en)
Inventor
Gregory Demopulos
George Gaitanaris
Roberto Ciccocioppo
Original Assignee
Omeros Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/835,607 external-priority patent/US9220715B2/en
Application filed by Omeros Corporation filed Critical Omeros Corporation
Priority claimed from PCT/US2013/039866 external-priority patent/WO2013176877A2/en
Publication of LT2846805T publication Critical patent/LT2846805T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
LTEP13793319.8T 2012-05-07 2013-05-07 Priklausomybių ir impulsų kontrolės sutrikimų gydymas, panaudojant pde7 inhibitorius LT2846805T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261643611P 2012-05-07 2012-05-07
US13/835,607 US9220715B2 (en) 2010-11-08 2013-03-15 Treatment of addiction and impulse-control disorders using PDE7 inhibitors
PCT/US2013/039866 WO2013176877A2 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors

Publications (1)

Publication Number Publication Date
LT2846805T true LT2846805T (lt) 2019-02-25

Family

ID=55442549

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13793319.8T LT2846805T (lt) 2012-05-07 2013-05-07 Priklausomybių ir impulsų kontrolės sutrikimų gydymas, panaudojant pde7 inhibitorius

Country Status (10)

Country Link
JP (4) JP2016138137A (lt)
CY (1) CY1121275T1 (lt)
DK (1) DK2846805T3 (lt)
ES (1) ES2711949T3 (lt)
HR (1) HRP20190279T1 (lt)
HU (1) HUE043518T2 (lt)
LT (1) LT2846805T (lt)
NZ (1) NZ628130A (lt)
PT (1) PT2846805T (lt)
RU (1) RU2665134C2 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250136832A1 (en) 2021-08-27 2025-05-01 Sumitomo Metal Mining Co., Ltd. Infrared curable ink composition, infrared cured product and method for producing infrared cured product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
BRPI0616344A2 (pt) * 2005-09-26 2011-06-14 Avigen Inc mÉtodo para o tratamento de dependÊncia quÍmica e comportamental
WO2008119057A2 (en) * 2007-03-27 2008-10-02 Omeros Corporation The use of pde7 inhibitors for the treatment of movement disorders
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
EP3788877B1 (en) * 2007-04-11 2024-08-07 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions

Also Published As

Publication number Publication date
HUE043518T2 (hu) 2019-08-28
NZ628130A (en) 2017-02-24
ES2711949T3 (es) 2019-05-08
JP2021138766A (ja) 2021-09-16
DK2846805T3 (en) 2019-03-18
JP6963431B2 (ja) 2021-11-10
JP2017171691A (ja) 2017-09-28
CY1121275T1 (el) 2020-05-29
HRP20190279T1 (hr) 2019-04-05
JP2019142980A (ja) 2019-08-29
JP2016138137A (ja) 2016-08-04
RU2014149192A (ru) 2016-07-10
RU2665134C2 (ru) 2018-08-28
PT2846805T (pt) 2019-02-27
HK1208373A1 (en) 2016-03-04

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
ZA202108991B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
GB2498121B (en) Treatment device and method of use
EP2887805A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
PL2825161T3 (pl) Inhibitory ludzkiej ezh2 i sposoby ich zastosowania
IL226203A0 (en) Use of pde7 suppressors and preparations containing them for the treatment of sales and disorders
SG11201504022RA (en) Glutamase inhibitors and method of use
IL237528A0 (en) Methods for preventing and treating preeclampsia
HRP20171352T1 (hr) Wnt-antagonisti i postupci liječenja
ZA201408055B (en) Compositions and methods for the treatment of local pain
GB201217296D0 (en) Method of treatment and/or prevention
IL232135A0 (en) Therapeutic combinations and methods for treating melanoma
SI2827883T1 (sl) Inhibitorji TFPI in postopki uporabe
ZA201607980B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
IL237887A0 (en) Devices and methods for encouraging hair growth
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
PL2846805T3 (pl) Leczenie uzależnień i zaburzeń kontroli impulsów za pomocą inhibitorów PDE7
LT2846805T (lt) Priklausomybių ir impulsų kontrolės sutrikimų gydymas, panaudojant pde7 inhibitorius
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
HK1189511A (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
GB201101688D0 (en) Treatment of porous structire and device therefor
ZA201501068B (en) Methods for prevention and treatment of preeclampsia